- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06930482
Evaluation of The Effectiveness of The SAFE Early Intervention Program
April 8, 2025 updated by: Ayse Simsek, Gazi University
Effect of SAFE Early Intervention Program on Neurodevelopmental Outcomes At 1 Year of Age in Infants at Risk of CP
In this study, it was aimed to examine the effect of SAFE, which is a sensory-based, activity-oriented early intervention approach applied in an enriched environment with family cooperation, on cognitive, language, motor and sensory development in 3-6 months old risky infants.
46 infants with neurodevelopmental risk, whose corrected age was 3 months, were included in the study.
Infants were randomly divided into two groups.
Infants in the treatment group were included in an early intervention program according to the SAFE approach.
Infants in the control group were included in the family education program based on the principles of Neurodevelopmental Therapy (NDT).
The intervention was performed for 12 weeks, and all infants were evaluated with Bayley Developmental Scale for Infants and Young Children III (Bayley III) by a blinded investigator before treatment (3rd months) after treatment (6th months) and 12th months.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Erzurum, Turkey
- Erzurum Technical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:• Corrected age of 3 months
- Any neurodevelopmental risk (perinatal stroke, perinatal asphyxia, HIE, GMK-IVK, PVL or gestational age of 32 and below)
Exclusion Criteria: • Having a congenital anomaly
- Having a genetic syndrome diagnosis (e.g. Down Syndrome)
- Parents do not speak Turkish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Control Group
|
The SAFE early intervention approach, an activity-focused, sensory intervention program, was applied to the babies in the intervention group in an enriched environment.
As part of the intervention, coaching was provided in collaboration with the family on how to support the baby's development.
For this purpose, family visits were made 15 days after the initial assessment and once a month.
During these visits, the suggestions given to the family were repeated and all questions about the process were answered.
It was discussed how the home environment should be structured in a way that is appropriate for the baby's development.
The aims of the approaches applied were explained and information was provided about the follow-up process.
In order to follow up on whether the family implemented the intervention, the family was interviewed by phone and the family was asked to keep an activity diary.
Within the scope of the study, NGT-based applications were applied to the babies included in the control group by their families.
After the first assessment, activities were planned to support skills appropriate to the child's developmental level.
The treatment movements, how to facilitate the baby's movements, and how to provide hand contact were demonstrated to the families in practice.
The applicability of the intervention program was monitored with weekly phone calls.
The babies were called to the clinic environment for a check-up every month to revise the intervention program and teach new movements, and an evaluation was made.
Two home visits were made to evaluate the families' home environments and parental attitudes (pre- and post-intervention).
|
|
Experimental: SAFE Early Intervention Group
|
The SAFE early intervention approach, an activity-focused, sensory intervention program, was applied to the babies in the intervention group in an enriched environment.
As part of the intervention, coaching was provided in collaboration with the family on how to support the baby's development.
For this purpose, family visits were made 15 days after the initial assessment and once a month.
During these visits, the suggestions given to the family were repeated and all questions about the process were answered.
It was discussed how the home environment should be structured in a way that is appropriate for the baby's development.
The aims of the approaches applied were explained and information was provided about the follow-up process.
In order to follow up on whether the family implemented the intervention, the family was interviewed by phone and the family was asked to keep an activity diary.
Within the scope of the study, NGT-based applications were applied to the babies included in the control group by their families.
After the first assessment, activities were planned to support skills appropriate to the child's developmental level.
The treatment movements, how to facilitate the baby's movements, and how to provide hand contact were demonstrated to the families in practice.
The applicability of the intervention program was monitored with weekly phone calls.
The babies were called to the clinic environment for a check-up every month to revise the intervention program and teach new movements, and an evaluation was made.
Two home visits were made to evaluate the families' home environments and parental attitudes (pre- and post-intervention).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Bayley Scales of Development for Infants and Toddlers III (Bayley-III)
Time Frame: 3 months,6 months, 12 months
|
3 months,6 months, 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
September 1, 2021
Study Completion (Actual)
January 1, 2023
Study Registration Dates
First Submitted
April 1, 2025
First Submitted That Met QC Criteria
April 8, 2025
First Posted (Actual)
April 16, 2025
Study Record Updates
Last Update Posted (Actual)
April 16, 2025
Last Update Submitted That Met QC Criteria
April 8, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 91610558-302.08.01-122723
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Ankara City Hospital BilkentRecruitingCerebral Palsy (CP) | Cerebral Palsy, Spastic, Diplegic | Diplegic Cerebral Palsy With Spasticity | Transcranial Magnetic StimilationTurkey (Türkiye)
-
Lahore University of Biological and Applied SciencesRecruiting
-
Suleyman Demirel UniversityCompletedCerebral Palsy | Hemiplegic Cerebral Palsy | Spastic Diplegia Cerebral PalsyTurkey (Türkiye)
-
Holland Bloorview Kids Rehabilitation HospitalCanadian Institutes of Health Research (CIHR)RecruitingCerebral Palsy (CP) | Hemiplegic Cerebral PalsyCanada
-
Cairo UniversityCompletedCerebral Palsy (CP) | Unilateral Cerebral PalsyEgypt
-
University of California, San FranciscoNot yet recruitingCerebral Palsy | Cerebral Palsy (CP) | Infant | Cerebral Palsy InfantileUnited States
-
Lahore University of Biological and Applied SciencesNot yet recruitingSpastic Diplegia Cerebral PalsyPakistan
-
IRCCS Fondazione Stella MarisNot yet recruitingCerebral Palsy (CP) | EEG | Unilateral Cerebral Palsy | Action ObservationItaly
-
IRCCS Fondazione Stella MarisUniversity of Siena, ItalyRecruitingCerebral Palsy (CP) | Motor Imagery | CP (Cerebral Palsy) | Action ObservationItaly
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
Clinical Trials on Safe early intervention
-
Gazi UniversityCompletedInfant, Premature, DiseasesTurkey
-
Gazi UniversityRecruitingPreterm | Neurodevelopmental Disorder (Diagnosis) | High Risk InfantTurkey (Türkiye)
-
Gazi UniversityCompletedPhysiotherapy | Infant Development | Early InterventionTurkey
-
Sarah BlaylockVA Office of Research and DevelopmentCompletedFall | Low VisionUnited States
-
Vanderbilt University Medical CenterRecruitingSafety Issues | Firearm InjuryUnited States
-
Sahlgrenska University HospitalCompletedHip Fracture | Urinary Retention | Adherence | Urinary Catheters | Documentation Skill | UTI - Urinary Tract Infection | Sustainability of InnovationsSweden
-
McGill University Health Centre/Research Institute...RecruitingFrailty | Fall Injury | Old Age; Atrophy | Age-Related Atrophy | Age-Related SarcopeniaCanada
-
Johns Hopkins Bloomberg School of Public HealthEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSudden Infant Death SyndromeUnited States
-
The University of Texas Health Science Center at...CompletedSecondary Prevention | Public Health | Sexually Transmitted Disease | Behavioral ModificationUnited States
-
University of BirminghamEthicon, Inc.; European Society of ColoproctologyRecruitingAnastomotic Leak | Anastomosis; ComplicationsRussian Federation